Related Experiment Video
Updated: Sep 8, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
Yong-Fu Zhu1,2, Shu-Jie Wang3, Jie Zhou2
1The First Department of Oncology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Abstract:
N6-methyladenosine (m6A) is a major internal epigenetic modification in eukaryotic mRNA, which is dynamic and reversible. m6A is regulated by methylases ("writers") and demethylases ("erasers") and is recognized and processed by m6A-binding proteins ("readers"), which further regulate RNA transport, localization, translation, and degradation. It plays a role in promoting or suppressing tumors and has the potential to become a therapeutic target for malignant tumors. In this review, we focus on the mutual regulation of m6A and coding and non-coding RNAs and introduce the molecular mechanism of m6A methylation involved in regulation and its role in cancer treatment by taking common female malignant tumors as an example.
Insights
N6-methyladenosine (m6A) is a key epigenetic regulator of RNA. This review explores how m6A interacts with RNA and its potential as a therapeutic target for female cancers.
Area of Science:
- Epigenetics
- Molecular Biology
- Oncology
Background:
- N6-methyladenosine (m6A) is a prevalent internal epigenetic modification in eukaryotic mRNA.
- m6A dynamics are controlled by writers, erasers, and readers, influencing RNA fate.
- m6A plays a dual role in tumor promotion and suppression, indicating therapeutic potential.
Purpose of the Study:
- To review the intricate interplay between m6A and both coding and non-coding RNAs.
- To elucidate the molecular mechanisms of m6A regulation.
- To examine the role of m6A in treating common female malignant tumors.
Main Methods:
- Literature review focusing on m6A regulation.
- Analysis of m6A's role in coding and non-coding RNAs.
- Case study of m6A in female cancers.
Main Results:
- m6A modification is dynamically regulated and impacts RNA processing.
- m6A influences gene expression and cellular processes relevant to cancer.
- Specific m6A patterns are associated with different female malignancies.
Conclusions:
- m6A is a critical regulator with significant implications for cancer biology.
- Understanding m6A mechanisms offers novel therapeutic strategies for female cancers.
- Targeting m6A pathways holds promise for improving cancer treatment outcomes.
Related Concept Videos
MicroRNAs
Epigenetic Regulation
X-chromosome...
Biosynthesis of Nucleic Acids
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Nuclear Export of mRNA
RNA Editing

